Northwest Biotherapeutics, Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
NWBO Over the counter 8731 http://www.nwbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Northwest Biotherapeutics, Inc

Independent Research on Trending Growth Companies: Northwest Biotherapeutics and Sanuwave Health - Feb 26th, 2018 5:45 am
NW Bio Congratulates Cognate BioServices On Its Management Buyout - Feb 20th, 2018 12:25 pm
NW Bio Announces Regulation D Offering for Accredited Investors - Dec 19th, 2017 10:32 am
NW Bio Announces Completion of $12 Million Financing - Dec 4th, 2017 11:39 am
NW Bio Reports Favorable Results and Progress In Resolving Lawsuits - Oct 30th, 2017 7:45 am
NW Bio Leases Out Warehouse On UK Property to Major Commodities Distribution Firm - Oct 17th, 2017 9:44 am
NW BIO Announces Registered Direct Offering Of $1.75 Million - Sep 20th, 2017 6:00 am
ETFs with exposure to Northwest Biotherapeutics, Inc. : September 6, 2017 - Sep 5th, 2017 7:39 pm
DCVax® Clinical Program Updates Presented By Dr. Marnix Bosch At Boston Scientific Conference - Sep 1st, 2017 12:49 pm
NWBio Closes 3-Year Convertible Debt Exchange and Financing, and Completes Payoff of Last $5 Million of 2014 Bonds - Jun 22nd, 2017 9:41 am
Dr. Marnix Bosch To Present Updates About DCVax® Clinical Programs Today - Jun 5th, 2017 7:17 am
Northwest Biotherapeutics, Inc. :NWBO-US: Earnings Analysis: Q1, 2017 By the Numbers : May 24, 2017 - May 24th, 2017 7:26 am